Financials

  • Market Capitalization 2.01 B
  • Employee 307
  • Founded 2018
  • CEO David Hung
  • Website www.nuvationbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VHJ0CC1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14.93
Relación precio/flujo de caja
0.05

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1977
ANAB
AnaptysBio, Inc. - Common Stock
69.81 USD+5.15%+12.18%+23.25%+98.32%2.03 B USD
1979
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
22.89 USD-3.05%+2.28%+25.63%+131.21%2.03 B USD
1989
ABCL
AbCellera Biologics Inc. - Common Shares
6.52 USD-4.12%-21.63%+19.20%+47.85%1.99 B USD
1990
SRPT
Sarepta Therapeutics, Inc. - Common Stock
18.82 USD-0.69%-2.34%+20.03%-3.59%1.99 B USD

Noticias